Thomas Stephen Basil

Insider profile

Thomas Stephen Basil's trades of Climb Bio Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-27 2026-02-26 PlS Planned sale
46,560 -27.8%
406.61
US$3,346,892
46,560 -27.8% 406.61 US$3,346,892
2026-02-27 2026-02-25 PlS Planned sale
44,962 +47.5%
408.43
US$3,270,572
44,962 +47.5% 408.43 US$3,270,572
2026-02-25 2026-02-25 PrS Proposed sale
98,661
434.12
US$3,375,666
98,661 434.12 US$3,375,666
2026-02-17 2026-02-13 PlS Planned sale
10,000 -4.7%
5.81
US$58,141
10,000 -4.7% 5.81 US$58,141
2026-02-17 2026-02-12 PlS Planned sale
90,000 -29.5%
5.23
US$470,988
90,000 -29.5% 5.23 US$470,988
2026-02-12 2026-02-12 PrS Proposed sale
100,000
5.56
US$556,000
100,000 5.56 US$556,000